Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis
Leptomeningeal metastases from solid tumors are a rare complication with a very poor prognosis. Here the authors report the efficacy and safety of combined ipilimumab and nivolumab in patients with leptomeningeal carcinomatosis.
類似資料
-
Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
著者:: Ayelet Eran, 等
出版事項: (2021-05-01) -
Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations
著者:: Craig Czyz, 等
出版事項: (2021-02-01) -
Multiple Dural Tuberculomas Presenting as Leptomeningeal Carcinomatosis
著者:: Hasan Kocaeli, 等
出版事項: (2011-01-01) -
Literature Review: Role of Neurosurgery in Leptomeningeal Carcinomatosis
著者:: Thaís Mitie Ogasawara, 等
出版事項: (2023-12-01) -
Leptomeningeal Carcinomatosis in a Patient with Ovarian Cancer
著者:: Özlem Kayım Yıldız
出版事項: (2019-09-01)